Clinical trial
Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in…
NCT00434291 · TaiGen Biotechnology Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00434291 |
|---|---|
| Title | Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia |
| Official title | A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP) |
| Lead sponsor | TaiGen Biotechnology Co., Ltd., Industry |
| Collaborators | Quintiles, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Community-Acquired Pneumonia |
| Intervention type | Drug |
| Interventions | TG-873870(Nemonoxacin) |
| Enrollment | 264 |
| Start date | Dec 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Feb 13, 2007 |
| Last update posted | Nov 25, 2009 |
| Countries | South Africa, Taiwan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: